125 related articles for article (PubMed ID: 7604141)
41. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
42. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
Bergstrom RF; Peyton AL; Lemberger L
Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
[TBL] [Abstract][Full Text] [Related]
43. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
[TBL] [Abstract][Full Text] [Related]
44. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
Bedada SK; Boga PK
Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of desipramine in Asian and Caucasian volunteers.
Pi EH; Tran-Johnson TK; Walker NR; Cooper TB; Suckow RF; Gray GE
Psychopharmacol Bull; 1989; 25(3):483-7. PubMed ID: 2626521
[TBL] [Abstract][Full Text] [Related]
46. 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
Stern SL; Ribner HS; Cooper TB; Nelson LD; Johnson MH; Suckow RF
J Clin Psychopharmacol; 1991 Apr; 11(2):93-8. PubMed ID: 2056147
[TBL] [Abstract][Full Text] [Related]
47. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
[TBL] [Abstract][Full Text] [Related]
48. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
[TBL] [Abstract][Full Text] [Related]
49. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Kim KA; Oh SO; Park PW; Park JY
Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression.
Szymura-Oleksiak J; Wyska E; Wasieczko A
Psychopharmacology (Berl); 2001 Feb; 154(1):38-42. PubMed ID: 11292004
[TBL] [Abstract][Full Text] [Related]
51. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
Moreland TA; Park BK; Rylance GW
Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
[TBL] [Abstract][Full Text] [Related]
52. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
[TBL] [Abstract][Full Text] [Related]
53. Altered hydroxydesipramine concentrations in elderly depressed patients.
Kitanaka I; Ross RJ; Cutler NR; Zavadil AP; Potter WZ
Clin Pharmacol Ther; 1982 Jan; 31(1):51-5. PubMed ID: 7053304
[TBL] [Abstract][Full Text] [Related]
54. An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.
Patroneva A; Connolly SM; Fatato P; Pedersen R; Jiang Q; Paul J; Guico-Pabia C; Isler JA; Burczynski ME; Nichols AI
Drug Metab Dispos; 2008 Dec; 36(12):2484-91. PubMed ID: 18809731
[TBL] [Abstract][Full Text] [Related]
55. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
Andreasen AH; Brøsen K; Damkier P
Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
[TBL] [Abstract][Full Text] [Related]
56. Antidepressant activity of 2-hydroxydesipramine.
Nelson JC; Mazure C; Jatlow PI
Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
[TBL] [Abstract][Full Text] [Related]
57. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
Sutfin TA; Perini GI; Molnar G; Jusko WJ
J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.
Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C
Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022
[TBL] [Abstract][Full Text] [Related]
59. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.
Bertilsson L; Tybring G; Widén J; Chang M; Tomson T
Br J Clin Pharmacol; 1997 Aug; 44(2):186-9. PubMed ID: 9278208
[TBL] [Abstract][Full Text] [Related]
60. Effect of carbamazepine on urinary volume and osmolality, water clearance, and serum osmolality in patients with primary enuresis.
Al-Waili NS; Al-Waili H; Saloom KY; Al-Waili T; Al-Waili A; Akmal M; Al-Waili F
Eur Urol; 2006 Oct; 50(4):844-9; discussion 849-50. PubMed ID: 16530927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]